Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy

被引：0
|
作者：
Aartsma-Rus, Annemieke [1 ]
Heemskerk, Hans [1 ]
de Winter, Christa [1 ]
van Putten, Maaike [1 ]
Janson, Anneke [2 ]
Verschuuren, Jan [3 ]
den Dunnen, Johan [1 ]
van Deutekom, Judith [2 ]
van Ommen, Gert-Jan [1 ]
机构：
[1] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[2] Prosensa Therapeut BV, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：660 / 661
页数：2
相关论文
共 50 条
  • [21] Development of antisense-mediated exon skipping for Duchenne: it takes more than an antisense oligonucleotide
    Rus, A.
    FEBS OPEN BIO, 2019, 9 : 50 - 50
  • [22] Exon skipping in Duchenne muscular dystrophy
    Wilton, Steve
    NEUROMUSCULAR DISORDERS, 2008, 18 (05) : 431 - 432
  • [23] Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy
    Chwalenia, Katarzyna
    Wood, Matthew J. A.
    Roberts, Thomas C.
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2025,
  • [24] A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
    Takenori Shimo
    Kana Hosoki
    Yusuke Nakatsuji
    Toshifumi Yokota
    Satoshi Obika
    Journal of Human Genetics, 2018, 63 : 365 - 375
  • [25] A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
    Shimo, Takenori
    Hosoki, Kana
    Nakatsuji, Yusuke
    Yokota, Toshifumi
    Obika, Satoshi
    JOURNAL OF HUMAN GENETICS, 2018, 63 (03) : 365 - 375
  • [26] Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy
    Echigoya, Yusuke
    Lim, Kenji Rowel Q.
    Trieu, Nhu
    Bao, Bo
    Nichols, Bailey Miskew
    Vila, Maria Candida
    Novak, James S.
    Hara, Yuko
    Lee, Joshua
    Touznik, Aleksander
    Mamchaoui, Kamel
    Aoki, Yoshitsugu
    Takeda, Shin'ichi
    Nagaraju, Kanneboyina
    Mouly, Vincent
    Maruyama, Rika
    Duddy, William
    Yokota, Toshifumi
    MOLECULAR THERAPY, 2017, 25 (11) : 2561 - 2572
  • [27] Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
    van Deutekom, Judith
    Beekman, Chantal
    Bijl, Suzanne
    Bosgra, Sieto
    van den Eijnde, Rani
    Franken, Dennis
    Groenendaal, Bas
    Harquouli, Bouchra
    Janson, Anneke
    Koevoets, Paul
    Mulder, Melissa
    Muilwijk, Daan
    Peterburgska, Galyna
    Querido, Bianca
    Testerink, Janwillem
    Verheul, Ruurd
    de Visser, Peter
    Weij, Rudie
    Aartsma-Rus, Annemieke
    Puolivali, Jukka
    Bragge, Timo
    O'Neill, Charles
    Datson, Nicole A.
    NUCLEIC ACID THERAPEUTICS, 2023, 33 (03) : 193 - 208
  • [28] The therapeutic potential of antisense-mediated exon skipping
    van Ommen, Gert-Jan
    van Deutekom, Judith
    Aartsma-Rus, Annemieke
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2008, 10 (02) : 140 - 149
  • [29] Antisense-mediated modulation of splicing Therapeutic implications for duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    RNA BIOLOGY, 2010, 7 (04) : 453 - 461
  • [30] Exon-Skipping in Duchenne Muscular Dystrophy
    Takeda, Shin ichi
    Clemens, Paula R.
    Hoffman, Eric P.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 : S343 - S358
12345